BJP Try Psychiatric Bulletin Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Journal of Mental Science (1961) 107: 287-293. doi: 10.1192/bjp.107.447.287
© 1961 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ashcroft, G. W.
Right arrow Articles by Barker, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ashcroft, G. W.
Right arrow Articles by Barker, P. A.

A Comparison of Tetrabenazine and Chlorpromazine in Chronic Schizophrenia

G. W. Ashcroft, M.B., M.R.C.P.E., D.P.M., M.R.C. Fellow In Clinical Research* and Elizabeth J. Macdougall, M.B., Ch.B., Registrar

Royal Edinburgh Hospital

P. A. Barker, M.B., M.R.C.P.E., D.P.M., D.C.H., Senior registrar, Child psychiatry Newcastle General Hospital*

This work was carried out when the first and third authors were registrars in the Craig House section of the Royal Edinburgh Hospital.

ABSTRACT

  1. A controlled trial was carried out to compare the efficacy of tetrabenazine with that of chlorpromazine in chronic schizophrenia. Fifty-two female patients in two matched groups were studied over a period of twenty weeks.
  2. Both groups of patients showed significant improvement during treatment. The trend was for chlorpromazine to be more active in controlling psychomotor over-activity and for tetrabenazine to be particularly effective in lessening thought disorder.
  3. Although side-effects caused suspension of treatment in five patients in the tetrabenazine group, the drug may be safely administered to patients in hospital and appears to be worthy of more extensive trial.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1961 The Royal College of Psychiatrists.